TP53 and cancer: While ACSL4 appears essential for ferroptosis in response to direct GPX4 inhibition, ferroptosis, as defined by the RTA-sensitive inhibition of lipid peroxidation and cell death, can be activated in cancer cells lacking ACSL4 by p53 expression [139], photodynamic therapy [140], and even system xCT inhibition [135].